The World Health Organization (WHO) recognizes the threat of antimicrobial resistance (AMR),
as we are losing effective medications to address resistant bacteria.
This “silent pandemic” poses a significant threat to humanity, with an estimated 10 million people per year at risk of being affected by AMR if no action is taken.
Someone must stand in the frontline to address this issue.

A&J Science was founded with the mission to target rare and intractable bacterial infections.
Our interest encompasses neglected infectious diseases,
and ultimately serving patients who need more effective medications.

To accomplish our dreams, we believe that scientific excellence is key to success.
Since the inception of the company, we have rigorously challenged our science by publishing our results in reputable scientific journals and conferences.
We recently opened a dedicated efficacy lab for infectious diseases to strengthen in targeting AMR.

We believe our comprehensive approaches will strengthen global alliances to tackle AMR, and to improve patients’ outcomes.

Thank you.